Cite
HARVARD Citation
Bascoul-Mollevi, C. et al. (2017). Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer. European journal of cancer. pp. 239-249. [Online].